MSc in Pharmacy by background, he obtained a PhD at the KU Leuven on the topic “Analysis of European policy towards generic medicines”. This PhD was part of the EGA Chair under the supervision of Prof. Dr. Steven Simoens. Pieter Dylst is currently a Health Economics Officer at the EGA. As part of the Market Access team, he is working to shape a dynamic and sustainable market situation that enables fast and fair pricing and reimbursement for generic, biosimilar and value added medicines in the EU, thereby improving and increasing the access for patients to affordable medicines.